IBRX vs U · rev $113.3M vs rev $1.85B
Immunitybio Inc (IBRX) versus Unity Software Inc (U) — a side-by-side from cached financials, not a winner call.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Unity Software Inc (U) is a software - application company listed on US.
Latest reported IBRX revenue for 2025-12-31 was $113.3M. Net income was -$351.4M. Revenue was up 668.3% from 2024-12-31 to 2025-12-31. IBRX currently screens at market cap $7.88B.
Latest reported U revenue for 2025-12-31 was $1.85B. Net income was -$402.8M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. U currently screens at market cap $16.98B.
IBRX currently screens at market cap $7.88B. U currently screens at market cap $16.98B.
Not investment advice. Open the IBRX and U stock pages for the full models.
Not investment advice.